T1	Participants 96 144	patients with advanced-stage Hodgkin's lymphoma:
T2	Participants 180 186	German
T3	Participants 359 397	advanced-stage Hodgkin's disease (HD).
T4	Participants 731 846	The randomized, three-arm trial recruited patients in stages IIB and IIIA with risk factors and stages IIIB and IV.
T5	Participants 1319 1342	505 assessable patients
